192 related articles for article (PubMed ID: 23792174)
1. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects.
Son HN; Nam JO; Kim S; Kim IS
Biochim Biophys Acta; 2013 Oct; 1833(10):2378-88. PubMed ID: 23792174
[TBL] [Abstract][Full Text] [Related]
2. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS
Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
4. A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo.
Ge H; Tian P; Guan L; Yin X; Liu H; Xiao N; Xiong Y; Luo X; Sun Y; Qi D; Ni S; Liu P
Exp Eye Res; 2013 Jul; 112():10-20. PubMed ID: 23562678
[TBL] [Abstract][Full Text] [Related]
5. ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
Tumbarello DA; Temple J; Brenton JD
Mol Cancer; 2012 May; 11():36. PubMed ID: 22640878
[TBL] [Abstract][Full Text] [Related]
6. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
[TBL] [Abstract][Full Text] [Related]
7. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E
Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753
[TBL] [Abstract][Full Text] [Related]
9. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
10. A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.
Desroches-Castan A; Quélard D; Demeunynck M; Constant JF; Dong C; Keramidas M; Coll JL; Barette C; Lafanechère L; Feige JJ
Oncotarget; 2015 Mar; 6(7):5382-411. PubMed ID: 25742784
[TBL] [Abstract][Full Text] [Related]
11. Transforming Growth Factor-induced Protein Promotes NF-κB-mediated Angiogenesis during Postnatal Lung Development.
Liu M; Iosef C; Rao S; Domingo-Gonzalez R; Fu S; Snider P; Conway SJ; Umbach GS; Heilshorn SC; Dewi RE; Dahl MJ; Null DM; Albertine KH; Alvira CM
Am J Respir Cell Mol Biol; 2021 Mar; 64(3):318-330. PubMed ID: 33264084
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Implications of Human Transforming Growth Factor β-Induced Protein, TGFBIp, in Corneal Dystrophies.
García-Castellanos R; Nielsen NS; Runager K; Thøgersen IB; Lukassen MV; Poulsen ET; Goulas T; Enghild JJ; Gomis-Rüth FX
Structure; 2017 Nov; 25(11):1740-1750.e2. PubMed ID: 28988748
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model.
Matsumoto K; Obara N; Ema M; Horie M; Naka A; Takahashi S; Imagawa S
Cancer Sci; 2009 Sep; 100(9):1639-47. PubMed ID: 19575748
[TBL] [Abstract][Full Text] [Related]
15. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.
Agrawal V; Maharjan S; Kim K; Kim NJ; Son J; Lee K; Choi HJ; Rho SS; Ahn S; Won MH; Ha SJ; Koh GY; Kim YM; Suh YG; Kwon YG
Oncotarget; 2014 May; 5(9):2761-77. PubMed ID: 24811731
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
[TBL] [Abstract][Full Text] [Related]
17. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.
Hamano Y; Zeisberg M; Sugimoto H; Lively JC; Maeshima Y; Yang C; Hynes RO; Werb Z; Sudhakar A; Kalluri R
Cancer Cell; 2003 Jun; 3(6):589-601. PubMed ID: 12842087
[TBL] [Abstract][Full Text] [Related]
18. Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
Rylova SN; Barnucz E; Fani M; Braun F; Werner M; Lassmann S; Maecke HR; Weber WA
J Nucl Med; 2014 Nov; 55(11):1878-84. PubMed ID: 25278514
[TBL] [Abstract][Full Text] [Related]
19. Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp.
Runager K; Basaiawmoit RV; Deva T; Andreasen M; Valnickova Z; Sørensen CS; Karring H; Thøgersen IB; Christiansen G; Underhaug J; Kristensen T; Nielsen NC; Klintworth GK; Otzen DE; Enghild JJ
J Biol Chem; 2011 Feb; 286(7):4951-8. PubMed ID: 21135107
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
Kessler T; Bieker R; Padró T; Schwöppe C; Persigehl T; Bremer C; Kreuter M; Berdel WE; Mesters RM
Clin Cancer Res; 2005 Sep; 11(17):6317-24. PubMed ID: 16144936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
